Our Leadership

Tom is a biotechnology founder and operator whose experience includes advancing an original therapeutic concept from preclinical development through FDA approval.

Over more than 25 years, he has founded 12 life sciences companies, participated in two initial public offerings—one as a founding employee and one as a founding board member—and completed partnership and co-development transactions.

His operating experience spans manufacturing, toxicology, clinical development, regulatory strategy and the recruitment and leadership of multidisciplinary teams. He has also secured non-dilutive financing and worked with scientific founders, academic researchers and industry partners to advance new technologies.

At Crosswalk, Tom leads scientific evaluation, portfolio strategy and company development. His responsibilities include management recruitment, development priorities, board leadership and strategic partnerships. His underwriting considers how the science, intellectual property, development pathway, financing and commercial proposition fit together—and what must be established before a company advances to its next stage.

Amy leads Crosswalk’s operations, compliance and governance, drawing on experience in investment management, bioscience and technology transfer.

She has more than 15 years of leadership experience across private funds, alternative investments and regulated financial businesses. Her work includes fund formation and administration, investor due diligence, regulatory examinations, compliance programs and supervisory systems.

Her bioscience experience includes managing a shared flow cytometry facility and performing protein X-ray crystallography protocols involving immunological proteins. In technology transfer, she supported confidentiality and material transfer agreements, patenting processes and technology licensing. She has also evaluated the intellectual property, business plans, management teams and financial condition of early-stage biotechnology companies.

At Crosswalk, Amy oversees fund operations, investor onboarding and reporting, governance processes, operational controls and service provider coordination. She works with company leadership and professional advisers to connect development activities with the financial, contractual and oversight requirements of the business.